Noviocell BV is a highly innovative biotech company. It focuses on the development of the first ever synthetic solution for 3D cell culturing, ranging from organoid growth to personalized medicine.
Click below on one of the items, or use the menu news.
A robust and valid alternative to other commercial systems for the fabrication of 3D hydrogels to be used as an advanced platform in tissue engineering.
Op dit moment is Noviocell voor de ontwikkeling van Noviogel volgens Van den Dolder vooral op zoek naar investeerders om de stap naar het ontwikkelen van diagnostische 3D modellen te maken.
This recent study published in Acta Biomaterialia (2018) confirms that fibroblasts, endothelial cells, adipose-derived stem cells and melanoma cells, do survive, thrive and differentiate in optimized PIC hydrogels. They support the spontaneous formation of complex structures like blood capillaries in vitro.